News
Video coverage of the meeting of institutional investors – 15.05.2017
A meeting of Celon Pharma S.A. with its institutional and individual investors took place on 15 May this year. We encourage you to see the video coverage of that meeting:
Celon Pharma S.A.’s Yearly Report for 2016
We encourage you to read Celon Pharma S.A.’s Yearly Report for 2016.
Celon Pharma S.A. among Business Sharks
Celon Pharma S.A. received an award during the Business Sharks 2016 Gala in the category “Debut of the Year 2016”. The award was accepted on behalf of the company by Iwona Giedronowicz, CFO, Member of the Board at Celon Pharma S.A. Business Sharks are awards given by “investorzy.tv”, presented to entrepreneurs and representatives of theRead more »
Celon Pharma’s IPO distinguished in the Stock Exchange Summary of the Year 2016
Celon Pharma S.A. was presented with another award given to leaders of the capital market – Stock Exchange Summary of the Year 2016. The company was awarded the Bull statuette in the category: Award for the highest value of the initial public offering in 2016. The award was accepted on behalf of the company byRead more »
Celon Pharma S.A. at the “CePT – Platform for innovative medicine development” conference
27 February 2017 Celon Pharma S.A. participated in a conference organised by the Centre of Preclinical Research and Technology which took place in the Educational Centre of the Medical University of Warsaw. Jerzy Pieczykolan, PhD, Head of the Department of Preclinical Trials at the R&D Centre of the Company presented a lecture entitled: “From theRead more »
Celon Pharma S.A. nominated for the Master of the Stock Exchange award
A list of 16 companies nominated for the award was composed by the journalists and analysts of “Puls Biznesu” and the Bankier.pl platform. According to Puls Biznesu, Celon Pharma S.A. is one of the eight front runners. The nomination justification especially pointed out the Company’s success associated with its début on the stock exchange inRead more »
Dr Maciej Wieczorek at the forefront of the Forbes magazine Business Leaders 2016 ranking
CEO of Celon Pharma S.A., Maciej Wieczorek, was ranked the third greatest representative of new pharmaceutical technologies. The distinction also underlined his innovative approach to building capital of Celon Pharma S.A. and high profitability of the Company which last year generated PLN 37 million net profit. The Business Leaders Ranking is a list of 25Read more »
Celon Pharma S.A.’s innovative research and development project among the projects on inflammatory diseases to receive co-financing from the National Centre for Research and Development
The project entitled “Selective JAK inhibitor in treatment of immune diseases” received co-financing in the amount of PLN 21,712,490.32 under the Smart Growth Operational Programme 2014-2020. The aim of the project is preclinical evaluation and clinical development (phase I and IIa trials conducted on patients) of an innovative drug candidate developed by the company toRead more »